CSII - Cardiovascular Systems, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue6/30/20176/30/20166/30/2015
Total Revenue204,906178,184181,544
Cost of Revenue39,44135,42139,520
Gross Profit165,465142,763142,024
Operating Expenses
Research Development22,91125,93430,977
Selling General and Administrative144,096162,542143,684
Non Recurring-10,36410,364
Others---
Total Operating Expenses---
Operating Income or Loss-1,542-56,077-32,637
Income from Continuing Operations
Total Other Income/Expenses Net-164145-71
Earnings Before Interest and Taxes-1,706-55,932-32,708
Interest Expense---
Income Before Tax-1,706-55,932-32,708
Income Tax Expense8692114
Minority Interest---
Net Income From Continuing Ops-1,792-56,024-32,822
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-1,792-56,024-32,822
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-1,792-56,024-32,822